These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 23382536)

  • 21. Rapid Somatic Mutation Testing in Colorectal Cancer by Use of a Fully Automated System and Single-Use Cartridge: A Comparison with Next-Generation Sequencing.
    Al-Turkmani MR; Godwin KN; Peterson JD; Tsongalis GJ
    J Appl Lab Med; 2018 Sep; 3(2):178-184. PubMed ID: 33636938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accuracy and reproducibility of somatic point mutation calling in clinical-type targeted sequencing data.
    Karimnezhad A; Palidwor GA; Thavorn K; Stewart DJ; Campbell PA; Lo B; Perkins TJ
    BMC Med Genomics; 2020 Oct; 13(1):156. PubMed ID: 33059707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular diagnostic characteristics based on the next generation sequencing in lung cancer and its relationship with the expression of PD-L1.
    Liu J; Liu Y
    Pathol Res Pract; 2020 Feb; 216(2):152797. PubMed ID: 31926773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. KRas and BRaf mutational status analysis from formalin-fixed, paraffin-embedded tissues using multiplex polymerase chain reaction-based assay.
    Jakubauskas A; Griskevicius L
    Arch Pathol Lab Med; 2010 Apr; 134(4):620-4. PubMed ID: 20367313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-throughput detection of clinically relevant mutations in archived tumor samples by multiplexed PCR and next-generation sequencing.
    Bourgon R; Lu S; Yan Y; Lackner MR; Wang W; Weigman V; Wang D; Guan Y; Ryner L; Koeppen H; Patel R; Hampton GM; Amler LC; Wang Y
    Clin Cancer Res; 2014 Apr; 20(8):2080-91. PubMed ID: 24573554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiplex picodroplet digital PCR to detect KRAS mutations in circulating DNA from the plasma of colorectal cancer patients.
    Taly V; Pekin D; Benhaim L; Kotsopoulos SK; Le Corre D; Li X; Atochin I; Link DR; Griffiths AD; Pallier K; Blons H; Bouché O; Landi B; Hutchison JB; Laurent-Puig P
    Clin Chem; 2013 Dec; 59(12):1722-31. PubMed ID: 23938455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of low-level KRAS mutations using PNA-mediated asymmetric PCR clamping and melting curve analysis with unlabeled probes.
    Oh JE; Lim HS; An CH; Jeong EG; Han JY; Lee SH; Yoo NJ
    J Mol Diagn; 2010 Jul; 12(4):418-24. PubMed ID: 20413678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biased estimates of clonal evolution and subclonal heterogeneity can arise from PCR duplicates in deep sequencing experiments.
    Smith EN; Jepsen K; Khosroheidari M; Rassenti LZ; D'Antonio M; Ghia EM; Carson DA; Jamieson CH; Kipps TJ; Frazer KA
    Genome Biol; 2014 Aug; 15(8):420. PubMed ID: 25103687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimization of melting analysis with TaqMan probes for detection of KRAS, NRAS, and BRAF mutations.
    Botezatu IV; Nechaeva IO; Stroganova АМ; Senderovich AI; Kondratova VN; Shelepov VP; Lichtenstein AV
    Anal Biochem; 2015 Dec; 491():75-83. PubMed ID: 26384642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intra- and inter-tumor heterogeneity of BRAF(V600E))mutations in primary and metastatic melanoma.
    Yancovitz M; Litterman A; Yoon J; Ng E; Shapiro RL; Berman RS; Pavlick AC; Darvishian F; Christos P; Mazumdar M; Osman I; Polsky D
    PLoS One; 2012; 7(1):e29336. PubMed ID: 22235286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coamplification at lower denaturation temperature-PCR increases mutation-detection selectivity of TaqMan-based real-time PCR.
    Li J; Wang L; Jänne PA; Makrigiorgos GM
    Clin Chem; 2009 Apr; 55(4):748-56. PubMed ID: 19233916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SP174, NRAS Q61R Mutant-Specific Antibody, Cross-Reacts With KRAS Q61R Mutant Protein in Colorectal Carcinoma.
    Lasota J; Kowalik A; Felisiak-Golabek A; Inaguma S; Wang ZF; Pięciak L; Zięba S; Pęksa R; Kopczynski J; Okoń K; Waloszczyk P; Gozdz S; Biernat W; Miettinen M
    Arch Pathol Lab Med; 2017 Apr; 141(4):564-568. PubMed ID: 28353383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of ARMS and DNA sequencing for mutation analysis in clinical biopsy samples.
    Ellison G; Donald E; McWalter G; Knight L; Fletcher L; Sherwood J; Cantarini M; Orr M; Speake G
    J Exp Clin Cancer Res; 2010 Oct; 29(1):132. PubMed ID: 20925915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Construction of a reference material panel for detecting
    Xu J; Qu S; Sun N; Zhang W; Zhang J; Song Q; Lin M; Gao W; Zheng Q; Han M; Na C; Xu R; Chang X; Yang X; Huang J
    J Clin Pathol; 2021 May; 74(5):314-320. PubMed ID: 32817175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variants with a low allele frequency detected in genomic DNA affect the accuracy of mutation detection in cell-free DNA by next-generation sequencing.
    Wang JF; Pu X; Zhang X; Chen K; Xi Y; Wang J; Mao X; Zhang J; Heymach JV; Antonoff MB; Hofstetter WL; Mehran RJ; Rice DC; Roth JA; Sepesi B; Swisher SG; Vaporciyan AA; Walsh GL; Meng QH; Shaw KR; Eterovic AK; Fang B
    Cancer; 2018 Mar; 124(5):1061-1069. PubMed ID: 29178133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of COLD-PCR and high-resolution melting analysis improves the limit of detection of KRAS and BRAF mutations in colorectal cancer.
    Mancini I; Santucci C; Sestini R; Simi L; Pratesi N; Cianchi F; Valanzano R; Pinzani P; Orlando C
    J Mol Diagn; 2010 Sep; 12(5):705-11. PubMed ID: 20616366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of parental mosaicism in
    de Lange IM; Koudijs MJ; van 't Slot R; Sonsma ACM; Mulder F; Carbo EC; van Kempen MJA; Nijman IJ; Ernst RF; Savelberg SMC; Knoers NVAM; Brilstra EH; Koeleman BPC
    J Med Genet; 2019 Feb; 56(2):75-80. PubMed ID: 30368457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of genome-wide low-frequency mutations with Paired-End and Complementary Consensus Sequencing (PECC-Seq) revealed end-repair-derived artifacts as residual errors.
    You X; Thiruppathi S; Liu W; Cao Y; Naito M; Furihata C; Honma M; Luan Y; Suzuki T
    Arch Toxicol; 2020 Oct; 94(10):3475-3485. PubMed ID: 32737516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of Circulating Tumor DNA in Patients with Pancreatic Cancer Using Digital Next-Generation Sequencing.
    Macgregor-Das A; Yu J; Tamura K; Abe T; Suenaga M; Shindo K; Borges M; Koi C; Kohi S; Sadakari Y; Dal Molin M; Almario JA; Ford M; Chuidian M; Burkhart R; He J; Hruban RH; Eshleman JR; Klein AP; Wolfgang CL; Canto MI; Goggins M
    J Mol Diagn; 2020 Jun; 22(6):748-756. PubMed ID: 32205290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MuSE: accounting for tumor heterogeneity using a sample-specific error model improves sensitivity and specificity in mutation calling from sequencing data.
    Fan Y; Xi L; Hughes DS; Zhang J; Zhang J; Futreal PA; Wheeler DA; Wang W
    Genome Biol; 2016 Aug; 17(1):178. PubMed ID: 27557938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.